Introduction
The condition known as juvenile nasopharyngeal angiofibroma (JNA), a term that was coined by Chauveau in 1906, was first documented during the time of Hippocrates (4 B.C.). 1 In a 1980 report, De Vincentiis and Pinelli reviewed a series of 704 cases of angiofibroma and found that only 13 (1.8%) had arisen outside the nasopharynx, illustrating the rarity of extranasopharyngeal angiofibroma (ENA). 2 A review of the literature by Windfuhr and Remmert published in 2004 found a total of 65 cases of ENA; the maxillary sinus was the most commonly involved site (24.6% of cases). 3 The ethmoid sinus is an extremely rare location for an ENA, as only 9 such cases have been previously reported in the international literature to date. 3, 4 The typical clinical characteristics of ENA in terms of age, sex, and symptoms do not conform to a great extent with those of JNA. This has led some to question whether ENA should be considered to be a completely different entity from JNA, despite their structural similarity. 5 In addition, Celik et al proposed that all angiofibromas whose clinical characteristics are different from those of classic angiofibroma should be referred to as atypical angiofibromas. 6 We report a new case of angiofibroma that originated in the ethmoid sinus. We also support the idea that ENA should be regarded as a separate entity from JNA.
Case report
A 16-year-old girl presented to our hospital with a 2-year history of left-sided nasal obstruction and recent episodes of epistaxis. Examination revealed telecanthus and a widening of the nasal dorsum. The patient's vision and ocular movements were normal.
Anterior rhinoscopy revealed that a large pinkish mass with a smooth surface had filled the left nasal cavity and pushed the septum to the opposite side. Posterior rhinoscopy showed that this mass was confined within the left posterior choana. On probing, the mass was soft to firm, nonfriable, insensitive to touch, and adherent to the lateral nasal wall. No regional lymphadenopathy was present, and findings on the rest of the ENT examination were normal.
Because the mass was easily accessible and because we did not expect to find an angiofibroma in a female patient, we performed a punch biopsy. However, this
The patient was prepared for surgery and administered general anesthesia. A lateral rhinotomy was performed. Intraoperatively, a large, firm, pinkish mass was found arising from the lateral wall of the nose in the anterior ethmoid area. The tumor was mobilized and removed en bloc by avulsing it from its attachment laterally (figure 2). The patient's postoperative course was uneventful. On histopathologic examination, the excised specimen exhibited features compatible with an angiofibroma (figure 3). There was no evidence of cellular atypia.
Again, in view of the rarity of angiofibroma in females, a chromosomal analysis of the patient was performed with an RPMI-1640 medium at a band resolution of 450 to 550 BPHS. This analysis revealed a normal female 46,XX chromosome complement with no numerical or structural chromosomal anomalies (figure 4).
Discussion
JNA is a well-defined entity sharply localized in time, space, and sex. Although angiofibromas commonly extend beyond the nasopharynx, they rarely originate outside it. 7 ENAs, which by definition do originate outside the nasopharynx, have virtually nothing in common with nasopharyngeal angiofibromas. ENAs are rare, benign neoplasms with a different biologic history and clinical features vis-à-vis the nasopharyngeal type. Therefore, they should be regarded as a separate clinical entity, and the use of the term angiofibroma to characterize this entity should be discontinued.
Compared with JNA, ENA affects patients at a later age, its symptoms develop more quickly, and hypervascularity is less common. 8 The clinical presentation of ENA depends mainly on the location and extent of the tumor. The general pattern of symptom progression in JNA as described by Schiff 9 (from nasal obstruction to epistaxis to skeletal deformities) is not seen in ENA.
As mentioned, the maxillary sinus is the most common site of ENA, and the ethmoid sinus is an extremely rare site. 3, 4 Other reported sites of ENA include the sphenoid sinus, nasal septum, middle and inferior turbinates, procedure led to profuse bleeding that required anterior nasal packing twice during the ensuing 72 hours. Histopathologic examination of the biopsy specimen identified features of an angiofibroma. The rarity of such a finding in a female patient prompted us to request that the pathology slides be reviewed again, and the reexamination confirmed the initial finding.
Contrast-enhanced computed tomography (CT) of the nose and paranasal sinuses showed that an enhancing mass had arisen from the left ethmoid labyrinth, pushed the septum to the opposite side, and expanded the medial wall of the maxillary sinus (figure 1). The mass extended into the posterior choana and indented the medial orbital wall. There was no bony disruption and no extension of the tumor into the anterior cranial fossa or nasopharynx. 4 Contrast-enhanced CT and magnetic resonance imaging are used to determine ENA site and extension. Special attention should be focused on skull base involvement, intracranial spread, and any relationships to important vascular and neurologic structures. Alvi et al considered CT to be sufficient for a diagnosis of ENA because it identifies and delineates the tumor clearly. 10 ENAs usually enhance with contrast; a failure to enhance sometimes occurs in tumors with little vascularity. 7 Endoscopic examination is warranted, but biopsy is ill-advised without adequate preparations for hemostasis and airway management. Because ENAs exhibit a tendency to local and less aggressive growth, the treatment of choice is surgical excision. Recurrences are rare. 3 We consider our case worth reporting because it adds to the very shallow pool of available clinical case reports of ENA arising from an anterior ethmoid sinus. The clinical presentation of this case mimicked that of a JNA. Because the biopsy of the lesion identified it as an angiofibroma, we believed that this case represented a rare case of JNA in a female patient. However, contrastenhanced CT showed that the lesion had arisen outside the nasopharynx, and this finding was confirmed during surgery. Hence the diagnosis of ENA of the anterior ethmoid sinus was established.
Our goals in writing this report were to emphasize that ENA and JNA are separate clinical entities and that otolaryngologists should be aware of this in order to avoid any serious surgical complications. As rare as it is, ENA should be taken into consideration in the differential diagnosis of nasal vascular tumors. Clinically, ENAs such as the one in our patient fall into that category of odd presentations that do not fit within the accepted clinical parameters that one expects to find in cases of JNA. Any other cases of ENA, especially in female patients, should be reported so that we can compile enough clinical data to characterize it as a distinct clinical entity rather than as a JNA. 
